Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- Xinjiang reports highest foreign trade growth in China
- Harbin authorities demand return of pensions paid out to deceased
- Global research project on AI guardrails launched in Beijing
- Partnering with China, embracing opportunities
- China's cyberspace regulators announce measures for protection of minors
- Beijing's 'Rocket Street' promoted at aerospace conference
